Physician Wealth Advisors’s Organon & Co OGN Stock Holding History

Physician Wealth Advisors’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$434	Hold	32	–	–	﹤0.01%	2200
2026 Q1	$192	Hold	32	–	–	﹤0.01%	2027
2025 Q4	$230	Hold	32	–	–	﹤0.01%	1996
2025 Q3	$342	Hold	32	–	–	﹤0.01%	1860
2025 Q2	$310	Hold	32	–	–	﹤0.01%	1759
2025 Q1	$477	Hold	32	–	–	﹤0.01%	1368
2024 Q4	$478	Buy	+32	New	+$522	﹤0.01%	1099

Other funds holding OGN

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Friedenthal Financial Marlton, New Jersey $217M AUM 21.15% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

AFAS

Acorn Financial Advisory Services Reston, Virginia $753M AUM 36.94% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Physician Wealth Advisors's OGN Position: Q2 2026 in Review

Physician Wealth Advisors held its Organon & Co (OGN) position steady in Q2 2026 at 32 shares worth $434. The position accounts for ﹤0.01% of the portfolio, ranked #2200.

Physician Wealth Advisors first reported a position in OGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $478 in Q4 2024. 101 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Physician Wealth Advisors held 32 shares of Organon & Co worth $434 as of Q2 2026.
Physician Wealth Advisors left its Organon & Co share count unchanged in Q2 2026.
Organon & Co made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #2200 holding.
Physician Wealth Advisors first reported a position in Organon & Co in Q4 2024 and has held it in 7 quarters since.
Physician Wealth Advisors's Organon & Co position peaked at $478 in Q4 2024.
101 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.